论文部分内容阅读
自1947年Mestwerdt使用“微癌”(microcarcinoma)这个术语以来,人们的注意力主要是在早期宫颈鳞癌上。Burghardt和Holzer认为微癌是一种肿瘤体积很小到不可能转移的癌,而并非是规定浸润深度在某一范围的癌。并定肿瘤体积500mm~3为微癌复发的上限。除他们外,对宫颈腺癌体积的重要性还未见报道。为此,作者研究了36例Ⅰ期宫颈腺癌的肿瘤体积和浸润的深度与淋巴转移和临床结果的相关性。并运用Burghardt和Holzer的方法计算肿瘤的体积,以便对罹患“微腺癌”(micro-adenocarcinoma)的病人提出行保守治疗的方案。
Since Mestwerdt used the term microcarcinoma in 1947, attention has been focused mainly on early cervical squamous cell carcinoma. Burghardt and Holzer that micro-cancer is a tumor size is small to impossible metastasis, rather than to specify the depth of invasion of a range of cancers. And set the tumor size of 500mm ~ 3 for the recurrence of micro-cancer limit. In addition to them, the importance of cervical adenocarcinoma volume has not been reported yet. To this end, the authors studied the relationship between the tumor size and the depth of invasion of 36 patients with stage I cervical cancer and lymph node metastasis and clinical outcome. The volume of the tumor was calculated using the method of Burghardt and Holzer in order to propose a conservative treatment plan for patients suffering from micro-adenocarcinoma.